FDA signs off on change to contraindications for GE's Optison agent
The U.S. Food and Drug Administration (FDA) has approved the removal of hypersensitivit...Read more on AuntMinnie.comRelated Reading:
Experts call for expanded use of ultrasound contrast agents
GE rolls out MyoSPECT cardiac nuclear medicine scanner
GE releases new fixed digital x-ray system
GE to acquire ultrasound firm BK Medical for $1.5B
Contrast group asks FDA to pull 'black box' warning
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
More News: Food and Drug Administration (FDA) | Nuclear Medicine | PET Scan | Radiology | Ultrasound | Warnings